Inspire Medical Systems, Inc. (INSP)

NYQ – Real Time Price. Currency in USD

44.06

+0.71 (1.64%)

At close: May 12, 2026, 4:00 PM EDT

05.05.2026

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Inspire Medical Systems, Inc. remains under pressure as Q1 revenue grew just 1.6% and management slashed 2026 guidance by up to 10%. INSP faces intensifying competition from GLP-1s and rival devices, reimbursement headwinds, and coding challenges with its new Inspire 5 system. Territory contraction and a shift to supporting existing accounts signal operational headwinds and a retreat from high-growth expansion.

05.05.2026

Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down

INSP beats Q1 estimates but slashes 2026 outlook as reimbursement disruptions and WISeR program weigh on growth and procedure volumes.

04.05.2026

Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript

04.05.2026

Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

04.05.2026

Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates

Inspire Medical Systems (INSP) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of a loss of $0.36 per share. This compares to earnings of $0.1 per share a year ago.

04.05.2026

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2026.

29.04.2026

Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference

MINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026. Inspire is scheduled to present at 11:00 a.m.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
INSP	Oppenheimer	Outperform	undefined >> $175	December 8th 2025
INSP	Morgan Stanley	Equal Weight	undefined >> $130	December 2nd 2025
INSP	Truist	Buy	undefined >> $165	November 26th 2025
INSP	Wolfe Research	Outperform	undefined >> $180	November 25th 2025
INSP	Stifel	Buy	undefined >> undefined	November 24th 2025
INSP	Wells Fargo	Overweight	undefined >> $90	November 4th 2025
INSP	Jefferies	Hold	undefined >> $85	October 24th 2025
INSP	UBS	Neutral	undefined >> $89	September 22nd 2025

Press releases

04.05.2026

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

02.03.2026

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August of 2025, contrary to the Company's repeated assurances that it had met all regulatory, technical, and commercial prerequisites for the launch of its Inspire V device, the Company disclosed that the launch faced an "elo.

14.02.2026

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

NEW YORK and NEW ORLEANS, Feb. 13, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.

11.02.2026

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Fourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42 Operating cash flow of $52.5 million in the fourth quarter with full year operating cash flow of $117.0 million MINNEAPOLIS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and year ended December 31, 2025. “We are very excited with the strong finish to 2025.

Inspire Medical Systems, Inc. (INSP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Inspire Medical Systems, Inc. (INSP)

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down

Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript

Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say

Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down

Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript

Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say

Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Search stocks

Inspire Medical Systems, Inc. (INSP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Inspire Medical Systems, Inc. (INSP)

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down

Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript

Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say

Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down

Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript

Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say

Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results